DrugPatentWatch Archives

You are currently viewing the 2002 archives
Click here to return to the current data set

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Applicant: Sanofi Synthelabo

Summary for Applicant: Sanofi Synthelabo

Drug Master File Entries: (click here to view)133
drug patent expirations by year for
 Sanofi Synthelabo
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Exclusivity Expiration
Sanofi Synthelabo
chloroquine phosphate
Tablet; Oral006002Approved prior to Jan 1, 1982RXYes<disabled><disabled>
Sanofi Synthelabo
chloroquine hydrochloride
Injectable; Injection006002Approved prior to Jan 1, 1982RXYes<disabled><disabled>
Sanofi Synthelabo
chloroquine phosphate; primaquine phosphate
Tablet; Oral014860Approved prior to Jan 1, 1982DISCNNo<disabled><disabled>
Sanofi Synthelabo
hydrochlorothiazide; irbesartan
Tablet; Oral020758AUG 31, 1998RXYes<disabled><disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
This search can help find similar names.

« Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology